• 1
    Gluud C, Afroudakis A, Caballeria J, et al. Diagnosis and treatment of alcoholic liver disease in Europe. First report. Gastroenterol Int 1993; 6: 22130.
  • 2
    Christensen E, Gluud C. Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. Gut 1995; 37: 1138.
  • 3
    Gluud C Alcoholic hepatitis: no glucocorticosteroids? In: LeuschnerU, JamesO, DancygierH, eds. FALK Symposium 121. Steatohepatitis (NASH and ASH). Vol. 121. Dordrecht/Boston/London: Kluwer Academic Publishers, 2001: 32342.
  • 4
    McCullough AJ, O’Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998; 93: 202236.
    Direct Link:
  • 5
    Mathurin P. Corticosteroids for alcoholic hepatitis – what’s next? J Hepatol 2005; 43: 52633.
  • 6
    Mihas AA. Alcoholic hepatitis. EMedicine From WebMD, 2006. .
  • 7
    Christensen E, Gluud C. Glucocorticosteroids are not effective in alcoholic hepatitis. Am J Gastroenterol 1999; 94: 30656.
    Direct Link:
  • 8
    Christensen E. Alcoholic hepatitis – glucocorticosteriods or not? J Hepatol 2002; 36: 5478.
  • 9
    Schulz KF, Chalmers I, Hayes R, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment in controlled trials. JAMA 1995; 273: 40812.
  • 10
    Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses. Lancet 1998; 352: 60913.
  • 11
    Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001; 135: 9829.
  • 12
    Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analyses may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 2008; 61: 6475.
  • 13
    Als-Nielsen B, Chen W, Gluud LL, et al. Are trial size and reported methodological quality associated with treatment effects? Observational study of 523 randomised trials In: 12th International Cochrane Colloquium. Ottawa, 2004: 1023. (Available at: Accessed January 23, 2007).
  • 14
    Montori VM, Devereaux PJ, Adhikari NK, et al. Randomised trials stopped early for benefit: a systematic review. JAMA 2005; 294: 22039.
  • 15
    Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. 4.2.5 [updated May 2005]. In: The Cochrane Library. Chichester: John Wiley & Sons, Ltd., 2005; 3: 1265.
  • 16
    Saconato H, Di Sena V, Gluud C, Christensen E, Atallah A. Glucocorticosteroids for alcoholic hepatitis (Protocol). Cochrane Database Syst Rev 1999; Issue 1. Art. No.: CD001511. DOI: DOI: 10.1002/14651858.CD001511.
  • 17
    Maddrey WC, Boitnott JK, Bedine MS, et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 1939.
  • 18
    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 153958.
  • 19
    Rambaldi A, Saconato HH, Christensen E, et al. Glucocorticosteroids for alcoholic hepatitis (Review). Cochrane Database Syst Rev 2008; Issue 3. Art. No.: CD001511. DOI: DOI: 10.1002/14651858.CD001511.
  • 20
    Helman RA, Temko MH, Nye SW, Fallon HJ. Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy. Ann Intern Med 1971; 74: 31121.
  • 21
    Porter HP, Simon FR, Pope CE II, et al. Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial. N Engl J Med 1971; 284: 13505.
  • 22
    Campra JL, Hamlin EM Jr, Kirshbaum RJ, et al. Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial. Ann Intern Med 1973; 79: 62531.
  • 23
    Blitzer BL, Mutchnick MG, Joshi PH, et al. Adrenocorticosteroid therapy in alcoholic hepatitis. A prospective, double-blind randomized study. Dig Dis 1977; 22: 47784.
  • 24
    Galambos JT. Unpublished trial. Quoted by Conn HO. Steroid treatment of alcoholic hepatitis. The yeas and the nays. Gastroenterology 1978; 74: 31922.
  • 25
    Mendenhall CL, Goldberg S. Risk factors and therapy in alcoholic hepatitis (AH). Gastroenterology 1977; 72: 1100.
  • 26
    Shumaker JB, Resnick RH, Galambos JT, et al. A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients. Am J Gastroenterol 1978; 69: 4439.
  • 27
    Depew W, Boyer T, Omata M, et al. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology 1980; 78: 5249.
  • 28
    Theodossi A, Eddleston AL, Williams R. Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. Gut 1982; 23: 759.
  • 29
    Mendenhall CL, Anderson S, Garcia-Pont P, et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 1984; 311: 146470.
  • 30
    Bories P, Guedj JY, Mirouze D, et al. Prednisolone treatment of alcoholic hepatitis: forty-five cases. Presse Med 1987; 16: 76972.
  • 31
    Carithers RL Jr, Herlong HF, Diehl AM, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 1989; 110: 68590.
  • 32
    Ramond MJ, Poynard T, Rueff B, et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992; 326: 50712.
  • 33
    Richardet JP, Dehoux M, Mal F, et al. Influence of corticosteroids (CS) on plasma cytokines concentrations in patients with severe alcoholic hepatitis (HA): results of a randomized study. J Hepatol 1993; 18: S75.
  • 34
    Conn HO. Steroid treatment of alcoholic hepatitis. The yeas and the nays. Gastroenterology 1978; 74: 31922.
  • 35
    Reynolds TB. Treatment of acute alcoholic hepatitis. Liver Transplantation Program and Center for Liver Diseases. (June 2006).
  • 36
    Lesesne HR, Bozymski EM, Fallon HJ. Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements. Gastroenterology 1978; 74: 16973.
  • 37
    Cabré E, Rodríguez-Iglesias P, Caballería J, et al. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 2000; 32: 3642.
  • 38
    Ioannidis JPA, Lau J. Evolution of treatment effects over time: empirical insight from recursive cumulative meta-analyses. Proc Natl Acad Sci U S A 2001; 98: 8316.
  • 39
    Gluud LL. Bias in clinical intervention research. Am J Epidemiol 2006; 163: 493501.
  • 40
    Als-Nielsen B, Gluud LL, Gluud C. Methodological quality and treatment effects in randomised trials – a review of six empirical studies. In: 12th International Cochrane Colloquium. Ottawa, 2004: 889. (Available at: Accessed January 23, 2007).
  • 41
    Wood L, Egger M, Gluud LL, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008; 336: 6015.
  • 42
    Gluud C. The culture of designing hepato-biliary randomised trials. J Hepatol 2006; 44: 60715.
  • 43
    Pogue J, Yusuf S. Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 1998; 351: 4752.
  • 44
    Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials BMJ 2005; 331: 31321.
  • 45
    Afshari A, Wetterslev J, Brok J, et al. Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis. BMJ 2007; 335: 124851.
  • 46
    Koretz RL, Lipman TO, Klein S. AGA technical review on parenteral nutrition. Gastroenterology 2001; 1214: 9701001.
  • 47
    Koretz RL, Avenell A, Lipman TO, et al. Does enteral nutrition affect clinical outcome? A systematic review of the randomized trials Am J Gastroenterol 2007; 102: 41229.
    Direct Link:
  • 48
    Rongey C, Kaplowitz N. Current concepts and controversies in the treatment of alcoholic hepatitis. World J Gastroenterol 2006; 12: 690921.